11/13
07:00 am
brtx
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
High
Report
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
11/12
04:12 pm
brtx
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
04:05 pm
brtx
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
11/6
07:00 am
brtx
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
Medium
Report
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium
11/5
07:12 am
brtx
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health [Yahoo! Finance]
Medium
Report
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health [Yahoo! Finance]
11/5
07:10 am
brtx
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
Medium
Report
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
10/31
07:00 am
brtx
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
Low
Report
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
10/10
07:00 am
brtx
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
Low
Report
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
10/3
04:15 pm
brtx
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
Low
Report
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
9/19
06:55 am
brtx
BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
Medium
Report
BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs